TVTY - Tivity Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
18.09
+0.20 (+1.12%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close17.89
Open18.05
Bid17.76 x 900
Ask19.55 x 1400
Day's Range17.89 - 18.38
52 Week Range14.84 - 41.46
Volume329,118
Avg. Volume834,179
Market Cap865.301M
Beta (3Y Monthly)0.89
PE Ratio (TTM)10.48
EPS (TTM)1.73
Earnings DateNov 4, 2019 - Nov 8, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est31.63
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents

    Edited Transcript of TVTY earnings conference call or presentation 7-Aug-19 9:00pm GMT

    Q2 2019 Tivity Health Inc Earnings Call

  • PR Newswire

    Tivity Health Leads National Strategy to Improve Health of Older Rural Americans

    NASHVILLE, Tenn., Aug. 14, 2019 /PRNewswire/ -- Tivity Health® (TVTY) is hosting its third annual Connectivity Summit on Rural Aging to promote healthy aging for rural Americans. The Summit will include an action-focused agenda that engages stakeholders from community and faith-based organizations, government, academia and the private sector to improve the health and well-being of rural seniors. This year's Connectivity Summit is focused on the conditions in which people live, work and age – also known as the social determinants of health – exploring how these factors impact the health of older Americans living in rural areas and solutions that can mitigate their impact.

  • Tivity Health, Inc. (TVTY) Q2 2019 Earnings Call Transcript
    Motley Fool

    Tivity Health, Inc. (TVTY) Q2 2019 Earnings Call Transcript

    TVTY earnings call for the period ending June 30, 2019.

  • Barrons.com

    Tivity Health, Fastly, Arcosa and Other 13D Filings

    Cloudera is in the Activist Spotlight, as Carl Icahn seeks to speak with the board and management about enhancing shareholder value and potentially seeking board representation.

  • A Note On Tivity Health, Inc.'s (NASDAQ:TVTY) ROE and Debt To Equity
    Simply Wall St.

    A Note On Tivity Health, Inc.'s (NASDAQ:TVTY) ROE and Debt To Equity

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

  • Tivity Health (TVTY) Q2 Earnings Lag Estimates
    Zacks

    Tivity Health (TVTY) Q2 Earnings Lag Estimates

    Tivity Health (TVTY) delivered earnings and revenue surprises of -3.03% and 0.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Tivity Health Reports Second-Quarter 2019 Results
    PR Newswire

    Tivity Health Reports Second-Quarter 2019 Results

    REPORTS REVENUES OF $340.4 MILLION REPAID $90 MILLION IN DEBT AS OF JULY 31, ONE YEAR AHEAD OF REQUIRED SCHEDULE UPDATES FINANCIAL GUIDANCE FOR 2019 BOARD OF DIRECTORS APPOINTS NEW INDEPENDENT DIRECTOR ...

  • 10 Small-Cap Stocks to Buy Before They Grow Up
    InvestorPlace

    10 Small-Cap Stocks to Buy Before They Grow Up

    One of the themes of this bull market has been that the best stocks to buy haven't been value plays -- and they haven't been small-cap stocks, either. Big growth names have outperformed; smaller stocks generally have not.Source: Shutterstock Indeed, as the Wall Street Journal noted just this week, small-cap stocks have underperformed large-caps by a full 15 percentage points over just the past year. Why exactly that is remains up for debate. Scale may be a greater asset in the modern business world -- particularly in tech. Or as some fear, the lack of enthusiasm toward small caps suggests worries about the near-term fate of the U.S. economy. * 7 Semiconductor Stocks to Buy for Your Inner Geek Whatever the case, in a market that lacks bargains, the small-cap stocks space offers a few. These 10 stocks to buy fit the traditional definition of small-cap stock with a market capitalization of $2 billion or less. All 10 have plenty of reasons to see those market capitalizations moving higher.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Turtle Beach (HEAR)Source: Shutterstock Gaming headset manufacturer Turtle Beach (NASDAQ:HEAR) has offered one of the more incredible rides of any stock in the market over the past few years. On a split-adjusted basis, the stock went from $80+ in 2013 to $2+ by early 2018. The numbers are 'split-adjusted' because Turtle Beach had to execute a reverse split in April of 2018 just to get its stock price above $1, and keep its NASDAQ listing. Bankruptcy seemed possible, if not likely.Then Fortnite happened. Demand skyrocketed. Weeks after the reverse split, earnings rose, and HEAR exploded. By August, the stock had gained 1,600% just in 2018. The narrative then turned again.After all, bears argued, Fortnite was supplying a short-term boost in demand. Turtle Beach's growth would reverse in 2019. That's exactly what happened -- and HEAR stock headed back to the single digits.But HEAR stock has rallied of late, and there should be more ahead. 2019 results are headed down, but that doesn't doom the company. The company still should be able to grow going forward, with many of the headsets sold in 2018 likely to be replaced in 2020 and 2021. Meanwhile, gaming-related stocks like Nvidia (NASDAQ:NVDA) and Logitech (NASDAQ:LOGI) are getting premium multiples, but HEAR stock remains cheap.Long story short, HEAR should have pulled back from $30+, but a decline to $10 looks like too much. And investors willing to use options can sell puts (as I have) to capitalize on still-high short interest in this small cap stock. Tivity Health (TVTY)Source: Shutterstock In the past two years, shares of small-cap stock Tivity Health (NASDAQ:TVTY) have plunged twice. TVTY stock fell 32% back in November 2017, when UnitedHealth Group (NYSE:UNH) announced it would provide a fitness benefit to Medicare Advantage members. That benefit competed with Tivity's Silver Sneakers program, which provides free gym visits for senior citizens under Medicare and private plans.TVTY stock dropped about the same, on a percentage basis, in December of last year, when the company acquired Nutrisystem. And the two plunges, about thirteen months apart, highlight the two key risks to Tivity Health stock.First, can the company survive in a healthcare space increasingly populated by giants? And, second, was the Nutrisystem deal a bad move? After all, Nutrisystem already had started struggling before Tivity acquired it.With TVTY down close to 60% from December highs, both risks look priced in. Silver Sneakers and the company's other programs are growing. And Nutrisystem was attractive enough as a business that I owned the shares ahead of the acquisition even with a slowdown. The combined company can offer real value to health care payors -- and to end customers. At this point, even if Tivity did overpay, it's lost about $1 billion in market capitalization -- getting close to equal to what it paid for Nutrisystem. * 4 Biotech Stocks Sliding Lower That's not to say the risks aren't real. They are. Q2 earnings, due in early August, likely will move the stock. But at 7x forward earnings, TVTY looks like not just a high-risk play, but a high-reward one as well. Century Casinos (CNTY)Source: Shutterstock The worry with Century Casinos (NASDAQ:CNTY) might be that at least a few investors already have figured out the story here. Century historically has been a sleepy stock, albeit one that has generated solid returns since the financial crisis. A lack of focus -- the company has operations in Poland and several Canadian markets, along with a now-smaller business running cruise ship casinos -- and a small size gave CNTY of a "best kept secret" kind of feel.But a recent deal with Eldorado Resorts (NASDAQ:ERI) changes that case and led CNTY to sky 12% before a recent pullback. Century is picking up three U.S. casinos while leasing the assets to REIT VICI Properties (NYSE:VICI). 96% of profits now come from North America, and Century got a great price, as Eldorado needed to divest the properties ahead of its planned merger with Caesars Entertainment (NASDAQ:CZR).That said, there's still a nice story, even if CNTY already has run up (gaining 30% so far this year). There are other small- to mid-sized properties Century can target if it wants to replicate Eldorado's successful growth-by-acquisition strategy. The balance sheet, even after the acquisitions, remains in good shape. Earnings are growing despite macroeconomic weakness in western Canada. And the small-cap stock, on a peer basis, remains cheap. There could -- and probably should -- be more upside ahead. Kulicke & Soffa (KLIC)Source: Shutterstock At first glance, semiconductor equipment manufacturer Kulicke & Soffa (NASDAQ:KLIC) looks like an awful stock -- even for a small-cap play. Sales in the first half of fiscal 2019 declined 37%. Analysts expect EPS this year of just $0.52 - against $2.43 the year before. And yet KLIC trades at almost 50x that consensus estimate.But Kulicke & Soffa is a semiconductor equipment manufacturer. That's a brutally cyclical industry, which explains why revenue has pulled back amid uneven chip demand. And the company has nearly $10 per share in cash on the balance sheet, which means its 'true' earnings estimates are much lower.Indeed, analysts are looking for a rebound in FY20 EPS to $1.77, albeit with a wide range. K&S' own guidance for fiscal Q3, which will be reported next week, suggests improving revenue trends. Should those fiscal 2020 earnings estimates be roughly in line, KLIC ex-cash trades for something like 8x forward EPS -- a very attractive multiple. And the long-term trends favoring semiconductor stocks -- 5G, IoT, autonomous driving, etc. -- all can help demand for Kulicke & Soffa products, even if that demand likely will stay choppy. * 7 Stocks to Buy That Save You Money In a market where chip names have rallied of late, including larger semicaps like Applied Materials (NASDAQ:AMAT) and Lam Research (NASDAQ:LRCX), KLIC has somewhat underperformed. Assuming demand bounces back -- and it should -- that will change in the coming quarters. Cannae Holdings (CNNE)Source: Shutterstock There are two aspects to the Cannae Holdings (NYSE:CNNE) bull case. The first is an attractive 'sum of the parts' argument. Cannae holds a stake in Ceridian HCM Holdings (NYSE:CDAY), which it is slowly divesting. Cannae also holds leveraged equity in Dun & Bradstreet, which it helped take private last year, along with other assets including restaurant chains. (Those chains, including O'Charley's and Village Square, have been the most disappointing part of the business so far.)On paper, then, CNNE has upside. But the second part of the bull case is that in practice, the cash coming from sales of Ceridian stock are going to a management team that has created huge shareholder value in past efforts. Cannae comes from the Fidelity National Financial (NYSE:FNF) tree, whose chairman Bill Foley has proven to be a masterful allocator of capital. Investors in CNNE basically are getting an opportunity to invest alongside Foley and his management team at a discount. Opportunities don't get much better than that. SailPoint Technologies (SAIL)Source: Shutterstock SailPoint Technologies (NYSE:SAIL) stumbled badly after its Q1 report in May. SAIL stock fell nearly 30% following a full-year guidance cut. But there's been a rally in recent weeks ahead of next month's second quarter release - and the story here isn't quite as bad as that price action suggested.SailPoint provides identity management software for businesses -- a space with obvious demand growth. And while SailPoint did cut guidance after the first quarter, the issues appear to be more related to execution than a slowing market. That's not necessarily great news, to be sure - but it does suggest a problem that can be fixed, rather than a permanent deceleration of growth that needs to be priced into SAIL.Meanwhile, even that lowered guidance suggests strong performance, with SailPoint looking for revenue to increase about 12%. Earnings are guided downward year-over-year, but should bounce back in 2020 and beyond. * 7 Semiconductor Stocks to Buy for Your Inner Geek The story here is dented but not broken. And with many software plays trading at nosebleed valuations -- including peer Okta (NASDAQ:OKTA), which is valued at almost 30x sales -- that could provide an opportunity. If SailPoint can right its ship (pardon the pun), there's room for huge gains. Boise Cascade (BCC)Source: Shutterstock There's a lot to like when it comes to Boise Cascade (NYSE:BCC). BCC stock is reasonably cheap, at a likely low double-digit multiple to 2019 adjusted EPS. The lumber producer is shifting its strategy, focusing on engineering wood in its Wood Products division and aiming to grow market share on the distribution side. That could drive growth and margin expansion going forward -- neither of which look priced into BCC right now.There are some risks. Debt is a modest concern, although manageable. The same is true of the company's pension expense, though the company moved ~60% of participants off its books last year. From an industry standpoint, the construction cycle needs to stay strong, and there is no shortage of housing-related stocks at similarly cheap multiples right now.Still, there's a nice under-the-radar story here -- and a nice combination of value and growth potential. PetIQ (PETQ)Source: Shutterstock The case for PetIQ (NASDAQ:PETQ) is much the same as it is other for other pet-centric plays. Americans, in particular, are spending more money on more pets every year. And so Chewy (NYSE:CHWY) has a market cap of $12 billion, and General Mills (NYSE:GIS) acquired Blue Buffalo for $8 billion. There is real growth in the U.S. pet market.PetIQ has two primary ways to play that growth. Its growing network of veterinary offices targets the services side. It sells products under national brands as well, including prescriptions. The latter category should be boosted by the $185 million acquisition of the animal services business of Perrigo (NYSE:PRGO).PetIQ has seen some choppy trading, and choppy performance, since its IPO in 2017. But the company, and the stock look to be back on track. Merck (NYSE:MRK) reportedly is considering an acquisition in the category, and PetIQ could be a target. On its own, market gains, the Perrigo acquisition, and share increases should allow the company to grow into a reasonable, if somewhat steep, ~30x forward P/E multiple. * Should You Buy or Sell These 5 Hot IPOs? Either way, both investors and acquirers have shown they'll pay up to enter the pet market and PETQ might be the most attractive play in it right now. Opera Limited (OPRA)Source: Shutterstock Small-cap stock Opera Limited (NASDAQ:OPRA) has an interesting story and a reasonable valuation. The Norwegian company provides web browsers -- both PC and mobile -- overseas, with over 350 million users. It's adding a fintech business -- including a microlending effort -- while looking to drive growth in developing markets in Africa and Asia.Those growth efforts are hitting profits this year - but OPRA stock still is reasonably cheap, at 19x 2020 EPS estimates. The company has no debt, which de-risks the story somewhat.To be sure, there's still risk. Competition from the likes of Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) and Microsoft (NASDAQ:MSFT) will remain intense. Developing markets raise macro exposure: advertisers may pull back on spending if domestic economies weaken. Even a stronger dollar could hit reported profits and value for U.S. investors.But in a market where seemingly every growth story is priced at a premium, Opera has an interesting story of its own. And the valuation is such that if that story plays out, the upside could be tremendous. Progress Software (PRGS)Source: Shutterstock Another software stock with an intriguing growth and value combination is Progress Software (NASDAQ:PRGS). Top-line growth for Progress has stalled out in recent years, but a 10% constant-currency increase in the fiscal second quarter suggests brighter days may be ahead. PRGS has jumped after its last two reports, including a huge gain after Q1 (thanks to second quarter guidance), but a recent pullback brings the price back into value territory. PRGS trades at less than 16x next year's earnings. * 10 Companies I'd Love to See Go Public On this site last month, Will Healy named PRGS one of 3 software stocks to buy. As Healy noted, Progress could be an acquisition target, particularly once it integrates its recent purchase of privately held Ipswitch. If fiscal 2019 results are any indication, PRGS should rally, whether on a buyout offer or on its own.As of this writing, Vince Martin is short puts in Turtle Beach and long shares of Cannae Holdings. He has no positions in any other securities mentioned.The post 10 Small-Cap Stocks to Buy Before They Grow Up appeared first on InvestorPlace.

  • Tivity Health to Issue Second Quarter 2019 Financial Results After Market Close on August 7
    PR Newswire

    Tivity Health to Issue Second Quarter 2019 Financial Results After Market Close on August 7

    NASHVILLE, Tenn. , July 23, 2019 /PRNewswire/ -- Tivity Health, Inc. (Nasdaq: TVTY) today announced that its financial results for the second quarter ending June 30, 2019 , will be released after market ...

  • Here's Why We Think Tivity Health (NASDAQ:TVTY) Is Well Worth Watching
    Simply Wall St.

    Here's Why We Think Tivity Health (NASDAQ:TVTY) Is Well Worth Watching

    For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

  • Nashville startup adds local public company's CEO to board
    American City Business Journals

    Nashville startup adds local public company's CEO to board

    GoCheck Kids, whose app screens children for vision impairments, moved its headquarters from Silicon Valley to Nashville last year.

  • Is Tivity Health, Inc. (TVTY) A Good Stock To Buy?
    Insider Monkey

    Is Tivity Health, Inc. (TVTY) A Good Stock To Buy?

    Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]

  • Moody's

    Tivity Health, Inc. -- Moody's announces completion of a periodic review of ratings of Tivity Health, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Tivity Health, Inc. New York, June 14, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Tivity Health, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Does The Tivity Health, Inc. (NASDAQ:TVTY) Share Price Tend To Follow The Market?
    Simply Wall St.

    Does The Tivity Health, Inc. (NASDAQ:TVTY) Share Price Tend To Follow The Market?

    If you own shares in Tivity Health, Inc. (NASDAQ:TVTY) then it's worth thinking about how it contributes to the...

  • TheStreet.com

    Hexo Names New Chief Financial Officer, Establishes Hexo USA

    named Michael Monahan as its chief financial officer Tuesday as it established a presence in the United States with Hexo USA. Monahan, who comes on board June 17, was most recently financial chief of Nutrisystem prior to its sale in March. Hexo said that during his tenure at Nutrisystem the company's market capitalization grew to $1.3 billion from about $250 million.

  • Dawn Zier: My advice to young adults entering the workforce
    American City Business Journals

    Dawn Zier: My advice to young adults entering the workforce

    For many successful people, their career wasn’t a straight path. So, don’t worry if you don’t know exactly what you want to be right now.

  • What health care execs can learn from Taylor Swift
    American City Business Journals

    What health care execs can learn from Taylor Swift

    “In health care, traditionally we are taught to be safe, we are regulated and taught not to be creative, but over time that will stifle innovation,” Sen. Bill Frist said. “I would argue that health care has a lot to learn from the music world.”

  • PR Newswire

    Nutrisystem Success Story Lisa Annunziata Loses 120 Pounds and Appears in PEOPLE's "How We Lost 100 Lbs." Feature Story in the June 3rd Issue (on Newsstands Friday, May 24)

    FORT WASHINGTON, Pa., May 22, 2019 /PRNewswire/ -- Nutrisystem®, Inc., a wholly-owned subsidiary of Tivity Health, Inc. (TVTY) and a leading provider of weight-management products and services, announced today that Nutrisystem Success Story, Lisa Annunziata, appears in the June 3, 2019 issue of PEOPLE in its popular "How We Lost 100 Lbs." feature story. Annunziata's journey began 24 years ago when she had her first son. "My "ah-ha" moment came when, as Human Resources VP, I was reviewing company benefits and determined we needed to create a Wellness Campaign to encourage employees to improve their health.

  • Thomson Reuters StreetEvents

    Edited Transcript of TVTY earnings conference call or presentation 8-May-19 9:00pm GMT

    Q1 2019 Tivity Health Inc Earnings Call

  • Tivity Health to Present at the William Blair 39th Annual Growth Stock Conference
    PR Newswire

    Tivity Health to Present at the William Blair 39th Annual Growth Stock Conference

    NASHVILLE, Tenn. , May 15, 2019 /PRNewswire/ -- Tivity Health, Inc. (NASDAQ: TVTY) will present at the William Blair 39th Annual Growth Stock Conference to be held June 5-6, 2019 in Chicago, IL. Donato ...

  • TheStreet.com

    Here's Why Nutrisystem Is a Healthy Investment for Tivity Health

    Tivity Health officially acquires Nutrisystem. Tivity Health's CEO explains why the acquisition is a healthy one for Tivity.

  • Should You Worry About Tivity Health, Inc.’s (NASDAQ:TVTY) ROCE?
    Simply Wall St.

    Should You Worry About Tivity Health, Inc.’s (NASDAQ:TVTY) ROCE?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • Business Wire

    TIVITY HEALTH INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Tivity Health, Inc. - TVTY

    Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Tivity Health, Inc. (TVTY). On November 6, 2017, a press release issued by United Healthcare (“UHC”), one of the Company’s most important health plan customers and the second largest in terms of revenue in 2016, announced the expansion of its fitness benefits to customers in 11 states, at no additional cost, through a program that would compete directly with Tivity’s flagship fitness product, which contradicted prior statements made by the Company regarding the status of its ongoing relationship with UHC. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws.

  • Top Ranked Growth Stocks to Buy for May 10th
    Zacks

    Top Ranked Growth Stocks to Buy for May 10th

    Top Ranked Growth Stocks to Buy for May 10th

  • Tivity Health is betting big on healthcare and nutrition
    Yahoo Finance Video

    Tivity Health is betting big on healthcare and nutrition

    Tivity Health, the company behind popular nutrition and health brands such as the South Beach Diet and Silver Sneaker, is betting big on health and fitness. The company recently acquired Nutrisystem for 1.3 billion dollars in cash and stock. Tivity Health CEO Donato Tramuto joined The Final Round to discuss.